Mriglobal - wagner dmfp
Ended Awarded Last action
- Contract number
- 75N95020F00001
- Awardee
-
Mriglobal UEI HKQHNFKNKL15
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,535,538
Award facts
- Contract value 100% obligated
- $1,535,538.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Kansas City, MO 64110, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $313,538 | |
| Funding Only Action | $129,445 | |
| Funding Only Action | $133,615 | |
| Original award | $958,940 |
About this award
This is a delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke to MRIGlobal, a not-for-profit research organization also known as Midwest Research Institute. The contract is part of the Drug Manufacturing and Formulation Program (DMFP) master IDIQ contract vehicle and has a potential value of $1,535,538.00. The contract does not have a set-aside designation. Under this contract, MRIGlobal will provide drug manufacturing and formulation services, leveraging its expertise in areas such as medical countermeasure development, biosafety testing, and pharmaceutical manufacturing. The contract includes the procurement of 6-bromo-3-chloro-4-methylpyridazine from subcontractor Bepharm Scientific Inc., doing business as Ambeed. This work supports the National Institute of Neurological Disorders and Stroke's research programs related to infectious disease prevention and new medical treatment development.
Quick answers
Who was awarded contract 75N95020F00001?
75N95020F00001 was awarded to Mriglobal by National Institute on Drug Abuse (National Institutes of Health) on August 18, 2020.
How much is contract 75N95020F00001 worth?
The government has obligated $1,535,538 on 75N95020F00001.
Which agency awarded contract 75N95020F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020F00001, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95020F00001 an order under another contract?
Yes. 75N95020F00001 is a delivery order under HHSN271201500006I, an indefinite delivery contract, on Drug Manufacturing and Formulation Program (DMFP).
Was contract 75N95020F00001 competed?
The extent of competition for 75N95020F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award